Gestrinone versus a gonadotropin-releasing hormone agonist for the treatment of pelvic pain associated with endometriosis: A multicenter, randomized, double-blind study

Fertility and Sterility

Volumn 66, Issue 6, 1996, Pages 911-919

  Vercellini, P ^a   Soma, M ^a   Moro, G L ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

dysmenorrhea; Endometriosis; gestrinone; GnRH agonists; leuprolide acetate; pelvic pain

Indexed keywords

GESTRINONE; GONADORELIN AGONIST; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEUPRORELIN; LIPOPROTEIN A; PLACEBO;

ADULT; ARTICLE; BONE DENSITY; BONE MINERAL; CHOLESTEROL BLOOD LEVEL; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG CAPSULE; DRUG EFFICACY; DUAL ENERGY X RAY ABSORPTIOMETRY; DYSMENORRHEA; DYSPAREUNIA; ENDOMETRIOSIS; FEMALE; HOT FLUSH; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; LAPAROSCOPY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PAIN ASSESSMENT; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UTERUS BLEEDING;

EID: 0030473141     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0015-0282(16)58682-8     Document Type: Article

References (25)

1. F. Parazzini Medical treatment for pelvic pain in endometriosis: an overview of studies on danazol, medroxyprogesterone acetate, gestrinone and gonadotropin releasing hormone agonist P.G. Crosignani P. Vercellini Endometriosis and pelvic pain 1994 Parthenon Publishing Casterton, United Kingdom 61 81
2. M.Y. Dawood J. Ramos F.S. Khan-Dawood Depot leuprolide acetate versus danazol for treatment of pelvic endometriosis: changes in vertebral bone mass and serum estradiol and calcitonin Fertil Steril 63 1995 1177 1183
3. E.M. Coutinho Treatment of endometriosis with gestrinone, a synthetic antiestrogen, antiprogesterone Am J Obstet Gynecol 144 1982 895 898
4. E.J. Thomas I.D. Cooke Impact of gestrinone on the course of asymptomatic endometriosis Br Med J 294 1987 272 274
5. P.L. Venturini S. Bertolini M.C. Marrè Brunenghi A. Daga V. Fasce A. Marcenaro Endocrine, metabolic, and clinical effects of gestrinone in women with endometriosis Fertil Steril 52 1989 589 595
6. M.D. Hornstein R.E. Gleason R.L. Barbieri A randomized double-blind prospective trial of two doses of gestrinone in the treatment of endometriosis Fertil Steril 53 1990 237 241
7. M. Worthington L.M. Irvine D. Crook B. Lees R.W. Shaw J.C. Stevenson A randomized comparative study of metabolic effects of two regimens of gestrinone in the treatment of endometriosis Fertil Steril 59 1993 522 526
8. The American Fertility Society Revised American Fertility Society classification of endometriosis: 1985 Fertil Steril 43 1985 351 352
9. K.O. Biberoglu S.J. Behrman Dosage aspects of danazol therapy in endometriosis: short-term effectiveness Am J Obstet Gynecol 139 1981 645 650
10. T.L. Kelly D.M. Slovik R.M. Neer Calibration and standardization of bone densitometers J Bone Miner Res 4 1988 663 669
11. H. Aray K. Ito K. Nagao M. Furutachi The evaluation of three different bone densitometry systems: XR26, QDR 1000 and DPX Image Technol Inform Disp 22 1990 495 500
12. N. Pokoc P. Sambrook T. Nguyen P. Kelly J. Freund J. Eisman Assessment of spinal and femoral bone density by dual x-ray absorptiometry: comparison of the lunar and hologic instruments J Bone Miner Res 7 1992 1081 1084
13. Lipid Research Clinic Program, National Institutes of Health, Lung, and Blood Institute Manual of laboratory operations. Vol. 1. Lipid and lipoprotein analysis 1974 National Institutes of Health Bethesda (MD) (revised 1982). DHEW Publication No. 75–628
14. M.R. Soma J. Osnago-Gadda R. Paoletti R. Fumagalli J.D. Morrisett M. Meschia The lowering of lipoprotein (a) induced by estrogen plus progesterone replacement therapy in postmenopausal women Arch Intern Med 153 1993 1462 1468
15. A.M. Dlugi J.D. Miller J. Knittle Lupron Study Group Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study Fertil Steril 54 1990 419 427
16. L. Fedele S. Bianchi L. Bocciolone G. Di Nola D. Franchi Buserelin acetate in the treatment of pelvic pain associated with minimal and mild endometriosis: a controlled study Fertil Steril 59 1993 516 521
17. S.M. Ott Editorial. Attainment of peak bone mass J Clin Endocrinol Metab 71 1990 1082A C
18. A. Rodin B. Murby M.A. Smith M. Caleffi I. Fentiman I. Fogelman Premenopausal bone loss in the lumbar spine and neck of femur: a study of 225 caucasian women Bone 11 1990 1 5
19. S. Dhuper M.P. Warren J. Brook-Gunn R. Fox Effects of hormonal status on bone density in adolescent girls J Clin Endocrinol Metab 71 1990 1083 1088
20. M.J. Tikkanen E.A. Nikkila T. Kussi S. Sipinen High density lipoprotein-2 and hepatic lipase: reciprocal changes produced by estrogen and norgestrel J Clin Endocrinol Metab 54 1982 1113 1117
21. D.J. Rader B.H. Brewer Lipoprotein (a). Clinical approach to a unique atherogenic lipoprotein JAMA 267 1992 1109 1112
22. G.H. Dahlen Lp(a) lipoprotein in cardiovascular disease Atherosclerosis 108 1994 111 126
23. A.A. Nabulsi A.R. Folsom A. White W. Patsch G. Heiss K.K. Wu Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women N Engl J Med 328 1993 1069 1075
24. J.L. Jenner J.M. Ordovas S. Lamon-Fava M.M. Schaefer P.W.F. Wilson W.P. Castelli Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels. The Framing-ham offsprings study Circulation 87 1993 1135 1141
25. M.R. Soma M. Meschia F. Bruschi J.D. Morrisett R. Paoletti R. Fumagalli Hormonal agents used in lowering lipoprotein(a) Chem Phys Lipids 67–68 1994 345 350